Thalidomide and immunomodulatory drugs in the treatment of cancer.
about
A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature.Community-acquired lung abscess caused by Legionella micdadei in a myeloma patient receiving thalidomide treatment.Targeting angiogenesis in melanoma
P2860
Thalidomide and immunomodulatory drugs in the treatment of cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@ast
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@en
type
label
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@ast
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@en
prefLabel
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@ast
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@en
P2860
P356
P1476
Thalidomide and immunomodulatory drugs in the treatment of cancer.
@en
P2093
Aristotle Bamias
P2860
P356
10.1517/13543784.14.1.45
P407
P577
2005-01-01T00:00:00Z